Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis

Fourat Ridouani,Thibaud Damy,Vania Tacher,Haytham Derbel,F. Legou,Islem Sifaoui,Etienne Audureau,Diane Bodez,Alain Rahmouni,Jean-François Deux

Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis

2018

Fourat Ridouani
Thibaud Damy
Vania Tacher
Haytham Derbel
F. Legou
Islem Sifaoui
Etienne Audureau
Diane Bodez
Alain Rahmouni
Jean-François Deux

Background To assess the diagnostic and prognosis value of myocardial native T2 measurement in the distinction between Light-chain (AL) and Transthyretin (ATTR) cardiac amyloidosis (CA).

Keywords:

Internal medicine
Cardiology
Cardiac amyloidosis
Transthyretin
Angiology
Medicine
Amyloidosis
Immunoglobulin light chain
t2 mapping

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations